Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

EPIGRAL LTD.

NSE : EPIGRALBSE : 543332ISIN CODE : INE071N01016Industry : ChemicalsHouse : Meghmani

BSE954.4054.15 (+6.01 %)

PREV CLOSE ( ) 900.25

OPEN PRICE ( ) 918.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3205

TODAY'S LOW / HIGH ( )894.20 957.30

52 WK LOW / HIGH ( )806.2 2114.3

NSE950.9049.25 (+5.46 %)

PREV CLOSE( ) 901.65

OPEN PRICE ( ) 905.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 101287

TODAY'S LOW / HIGH( ) 892.45 957.00

52 WK LOW / HIGH ( )807 2114

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-08 2007

Management Info

Maulik Patel - Chairman Maulik Patel - Managing Director

Registered Office

Address ‘ Epigral Tower’,Behind Safal Profitaire, Corporate Road,Nr. Auda Garden, Prahlad Nagar,
Ahmedabad,
Gujarat-380015

Phone 079-71761000 / 29709600

Email info@epigral.com

Website www.epigral.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

04Apr Epigral informs about analyst meet
Epigral has informed that the Company is participating in Non-Deal Roads..

15Jan Epigral informs about analyst meet
Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing..

01Jan Epigral informs about disclosure
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

17Nov Epigral informs about investor call
Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing..

12Nov Epigral informs about press release
Epigral has informed that it enclosed the copies of newspaper advertisem..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	391.5	3567
Gross Profit	546	5401
Operating Profit	1083	7259.3
Net Sales	5971.2	25501.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Keltech Energies (BSE) 3443.00 (8.16%)	M.Cap ( in Cr)341.00
Solar Industries (BSE) 13410.00 (0.84%)	M.Cap ( in Cr)121253.96
Fine Organic Inds. (BSE) 4401.45 (1.68%)	M.Cap ( in Cr)13521.82
Atul (BSE) 6219.00 (1.18%)	M.Cap ( in Cr)18273.61
BASF India (BSE) 3356.00 (2.03%)	M.Cap ( in Cr)14500.69

Shareholding Pattern

	PROMOTERS	68.83%
	NON-INSTITUTION	23.66%
	MUTUAL FUNDS/UTI	5.09%
	GOVERNMENT	0.02%
	FI/BANKS/INSURANCE	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
HSBC Focused Fund-Reg(G)	2.63
HSBC Tax Saver Equi...	1.23
HSBC Business Cycle...	1.20
ITI Small Cap Fund-Reg(G)	1.00
Bandhan Business Cy...	1.00
ITI Multi-Cap Fund-Reg(G)	0.99
HSBC India Export O...	0.94

Risk Disclosures on Derivatives

Smart Quotes

EPIGRAL LTD.